Kenneth A. Stauderman, Chief Scientific Officer at CalciMedica, Inc. (CALC), bought 1,000 shares at $1.85 ($2K) on 2025-07-01, disclosed to the SEC on 2025-07-02.
Open-market purchase of $2k CALC by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |